New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients
Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more than 20 years ZEPZELCA approval granted under a provisional regulatory pathway US FDA and TGA collaborated via ‘Project Orbis’ to accelerate availability to…
Comments Off on New Therapy to Treat Advanced Small Cell Lung Cancer Approved for Australian Patients